ELCC 2019: Industry Participation

The European Lung Cancer Congress 2019 (ELCC 2019), is the most important congress in Europe for all clinical practitioners involved in the diagnostic work-up and treatment of lung cancer and other thoracic malignancies.

It brings together a unique community of medical professionals to facilitate the advancement of a personalised approach to the management of lung and other thoracic cancers and the implementation of new discoveries into clinical practice.

Fast facts: ELCC 2019

  • Expecting over 2000 international participants
  • Specialists and Key Opinion Leaders (KOLs) from all over the world in one place and as one community
  • 16 educational and 4 key note lectures sessions running over four days
  • An internationally renowned faculty
  • 9 Industry Satellite Symposia
  • Vibrant commercial exhibition
  • Excellent networking opportunities

Past attendance

ESMO gratefully acknowledges the valuable contribution of the following organisations in the ELCC Congresses over the years.

Past attendees
Abbott Laboratories Clovis Oncology Novartis
AbbVie Daiichi Sankyo Europe Olympus Medical Systems Europe
Agennix Elsevier Otsuka Pharmaceuticals
Amgen Epigemonics Pfizer Oncology
Amoy Diagnostics Co. Ltd GE Healthcare PharmaMar, S.A.
Ariad Pharmaceuticals GSK prIME Oncology
AstraZeneca Helsinn Healthcare Qiagen
Bavarian Nordic Incyte Corporation Roche
Bayer Schering Pharma Karl Storz Rosetta Genomics
Beacon Medicare Ltd Lilly Oncology Sanofi
Biocartis Merck Serono Sysmex Europe GmbH
Boehringer Ingelheim Merck-Pfizer Alliance Takeda Pharmaceuticals International AG
Bristol-Myers Squibb Microsulis Medical Ltd. Varian Medical Systems
Cis Bio International MSD Wisepress Ltd

How can I participate in ELCC 2019?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congresses.

Contact the  ESMO Events Sponsorship Team for more details. We look forward to hearing from you!